p53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver Cancer

Research output: Contribution to journalJournal articleResearchpeer-review

  • Darjus F Tschaharganeh
  • Wen Xue
  • Diego F Calvisi
  • Matthias Evert
  • Tatyana V Michurina
  • Lukas E Dow
  • Ana Banito
  • Sarah F Katz
  • Edward R Kastenhuber
  • Susann Weissmueller
  • Chun-Hao Huang
  • Andre Lechel
  • Andersen, Jesper Bøje
  • David Capper
  • Lars Zender
  • Thomas Longerich
  • Grigori Enikolopov
  • Scott W Lowe

The p53 tumor suppressor coordinates a series of antiproliferative responses that restrict the expansion of malignant cells, and as a consequence, p53 is lost or mutated in the majority of human cancers. Here, we show that p53 restricts expression of the stem and progenitor-cell-associated protein nestin in an Sp1/3 transcription-factor-dependent manner and that Nestin is required for tumor initiation in vivo. Moreover, loss of p53 facilitates dedifferentiation of mature hepatocytes into nestin-positive progenitor-like cells, which are poised to differentiate into hepatocellular carcinomas (HCCs) or cholangiocarcinomas (CCs) in response to lineage-specific mutations that target Wnt and Notch signaling, respectively. Many human HCCs and CCs show elevated nestin expression, which correlates with p53 loss of function and is associated with decreased patient survival. Therefore, transcriptional repression of Nestin by p53 restricts cellular plasticity and tumorigenesis in liver cancer.

Original languageEnglish
JournalCell
Volume158
Issue number3
Pages (from-to)579-92
Number of pages14
ISSN0092-8674
DOIs
Publication statusPublished - 31 Jul 2014

ID: 120012112